Abbott vence processo de acionistas sobre recall de fórmulas infantis de 2022

· insurancejournal.com

Um juiz federal rejeitou, em 24 de julho, um processo que acusava a Abbott Laboratories de fraudar acionistas ao minimizar e tentar se esquivar de sua

A federal judge on July 24 dismissed a lawsuit accusing Abbott Laboratories of defrauding shareholders by downplaying and trying to evade its responsibility for...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI